Programs and projects cut across themes, bringing multi-sectoral and multidisciplinary perspectives to bear on these challenges. CANet provides the biotechnology industry with opportunities to develop, test and market new technologies and therapies for the diagnosis and treatment of arrhythmias.
Research from our Network has a significant impact on health and wealth creation in Canada.
Every CANet-funded project includes a patient partner. Patients are represented one every CANet committee. From governance to research to disease management, patients are co-leaders in CANet.